FNDC5/Irisin-dependent renoprotection of resistance training in myocardial infarction-induced Type 2 cardiorenal syndrome. [PDF]
Fu W, Lin J, Lin W, Zeng K.
europepmc +1 more source
Association between relative fat mass and chronic cardiorenal syndrome: A cross-sectional study based on NHANES 1999 to 2018. [PDF]
He Y, Quan Z, Huang D.
europepmc +1 more source
Serum peptidomic profiling and peptide mass fingerprinting reveal signatures associated with peroxisomal and mitochondrial pathways in MMVD-associated cardiorenal syndrome in dogs. [PDF]
Pichayapaiboon P +7 more
europepmc +1 more source
Diuretic resistance in cardiorenal syndrome: mechanisms, monitoring and phenotype-tailored management. [PDF]
Aletras G +7 more
europepmc +1 more source
The Role of Chloride in Cardiorenal Syndrome: A Practical Review. [PDF]
Aletras G +8 more
europepmc +1 more source
Comparison of Cardiorenal Syndrome and Heart Failure: A Preliminary Study of Clinical, Cognitive, and Emotional Aspects. [PDF]
Pagano M +12 more
europepmc +1 more source
Current Perspectives on the NF-κB Signaling Axis as a Potential Pharmacological Target in Cardiorenal Syndrome. [PDF]
Liu Q +5 more
europepmc +1 more source
Feasible predictors of cardiorenal syndrome (type 2)
Introducere. Sindromul cardiorenal cronic, tipul 2 (SCRC2) impune evoluţia perpetuată a disfuncţiei renale ca consecinţă a afecţiunilor cardiace cronice, în primul rând a insuficienţei cardiace. Un algoritm de predicţie concludentă asigură diagnosticarea
Dogari, Adelina
core
The right heart perspective in chronic cardiorenal syndrome: the key role of right heart function and tricuspid regurgitation innovation. [PDF]
Yin X, Tang L, Liu J, Zhang Y.
europepmc +1 more source
Cardiorenal Syndrome in Adults with Congenital Heart Disease. [PDF]
Upadhyay S +4 more
europepmc +1 more source

